Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Toll Brothers, Inc. · TOL · FY2026 Q2 · Calendar Q2 2026
The Q2 evidence supports a constructive but conditional view: strong luxury move-up demand, raised guidance, disciplined spec inventory, and geographic expansion support continued growth, while rates, costs, regional weakness, and mix remain material tests.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Compared with the prior quarter, management raised the full-year outlook, reported a higher luxury move-up revenue mix, reduced finished spec inventory, and added the Buffington Homes acquisition and Northwest Arkansas expansion. The prior quarter's guidance had been maintained.
Raised: full-year delivery guidance to 10,400–10,700 homes, average price to $985,000–$1 million, and adjusted gross margin to 26.1%.
Follow TOL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 28, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 21, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 20, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 14, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Apr 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 23, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 19, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Feb 19, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Feb 18, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 10, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Argus Research | Buy | Buy | Maintain | Sep 5, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 25, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 8, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 24, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 23, 2023 |
| Keybanc | Underweight | Upgrade | Sep 19, 2022 | |
| BTIG | Neutral | Sell | Upgrade | Jun 28, 2021 |
| Susquehanna | Neutral | Positive | Downgrade | Oct 14, 2019 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Aug 13, 2019 |
| Mizuho | Neutral | Buy | Downgrade | Jan 23, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Oct 18, 2018 |
| Maxim Group | Buy | Buy | Maintain | May 23, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| BTIG Research | Neutral | Neutral | Maintain | Feb 8, 2017 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Aug 24, 2016 |
| Buckingham Research | Buy | Buy | Maintain | Aug 24, 2016 |
| Zelman | Hold | Buy | Downgrade | Apr 20, 2016 |
| JMP Securities | Market Perform | Outperform | Downgrade | Jan 25, 2016 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Oct 13, 2015 |
| Sterne Agee CRT | Neutral | Underperform | Upgrade | May 18, 2015 |
| Sterne Agee | Neutral | Underperform | Upgrade | May 18, 2015 |
| Compass Point | Neutral | Neutral | Maintain | Feb 26, 2014 |
| MKM Partners | Buy | Neutral | Upgrade | Jun 4, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jan 7, 2013 |
| Stifel Nicolaus | Hold | Sell | Upgrade | Jan 3, 2013 |
| Stifel | Hold | Sell | Upgrade | Jan 3, 2013 |
| Topeka | Hold | Hold | Maintain | Dec 7, 2012 |
| Williams Capital | Hold | Hold | Maintain | Dec 5, 2012 |
| FBN Securities | Underperform | Sector Perform | Downgrade | Jul 6, 2012 |
| Williams Financial | Hold | Hold | Maintain | Mar 12, 2012 |
Upside is calculated against the persisted previous close $135.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $191 | $148.58 | +41.2% | Aug 20, 2026 |
| UBS | Analyst unavailable | $195 | $148.58 | +44.2% | Aug 20, 2026 |
| Barclays | Matthew Bouley | $122 | $148.15 | -9.8% | Jul 14, 2026 |
| Argus Research | Analyst unavailable | $170 | $138.88 | +25.7% | Jun 2, 2026 |
| UBS | Analyst unavailable | $187 | $132.86 | +38.2% | May 21, 2026 |
| RBC Capital | Analyst unavailable | $158 | $132.82 | +16.8% | May 21, 2026 |
| Evercore ISI | Analyst unavailable | $185 | $132.63 | +36.8% | May 21, 2026 |
| Truist Financial | Jonathan Bettenhausen | $170 | $139.47 | +25.7% | Apr 16, 2026 |
| Truist Financial | Jonathan Bettenhausen | $190 | $153.66 | +40.5% | Mar 3, 2026 |
| RBC Capital | Mike Dahl | $161 | $160.42 | +19.0% | Feb 19, 2026 |
| UBS | John Lovallo | $198 | $161.93 | +46.4% | Feb 19, 2026 |
| Evercore ISI | Analyst unavailable | $174 | $161.94 | +28.6% | Feb 19, 2026 |
| Oppenheimer | Analyst unavailable | $180 | $160 | +33.1% | Feb 19, 2026 |
| Wells Fargo | Sam Reid | $185 | $160 | +36.8% | Feb 19, 2026 |
| Oppenheimer | Analyst unavailable | $177 | $157.08 | +30.8% | Feb 10, 2026 |
| Wells Fargo | Sam Reid | $170 | $148.81 | +25.7% | Jan 14, 2026 |
| Goldman Sachs | Analyst unavailable | $156 | $146.93 | +15.3% | Jan 13, 2026 |
| Goldman Sachs | Susan Maklari | $140 | $138.55 | +3.5% | Dec 10, 2025 |
| RBC Capital | Mike Dahl | $144 | $135.21 | +6.5% | Dec 10, 2025 |
| Barclays | Matthew Bouley | $110 | $132.9 | -18.7% | Dec 10, 2025 |
| UBS | Analyst unavailable | $181 | $132.9 | +33.8% | Dec 10, 2025 |
| UBS | John Lovallo | $183 | $134.45 | +35.3% | Dec 9, 2025 |
| UBS | Analyst unavailable | $161 | $142.71 | +19.0% | Dec 4, 2025 |
| Evercore ISI | Analyst unavailable | $160 | $140.74 | +18.3% | Oct 7, 2025 |
| Oppenheimer | Tyler Batory | $155 | $106.38 | +14.6% | May 15, 2025 |
| Wedbush | Jay McCanless | $175 | $149.02 | +29.4% | Oct 25, 2024 |
| RBC Capital | Mike Dahl | $143 | $141.03 | +5.7% | Aug 22, 2024 |
| Barclays | Matthew Bouley | $116 | $133.86 | -14.2% | Aug 20, 2024 |
| Evercore ISI | Stephen Kim | $180 | $123.15 | +33.1% | Jul 15, 2024 |
| Needham | Ryan MacDonald | $77 | $119.24 | -43.1% | Jun 17, 2024 |
| Goldman Sachs | Susan Maklari | $124 | $119.32 | -8.3% | Jun 17, 2024 |
| Argus Research | Chris Graja | $140 | $120.25 | +3.5% | Jun 6, 2024 |
| Barclays | Matthew Bouley | $118 | $122.91 | -12.8% | May 28, 2024 |
| Wolfe Research | Truman Patterson | $135 | $119.56 | -0.2% | May 23, 2024 |
| RBC Capital | Mike Dahl | $300 | $120.55 | +121.8% | May 23, 2024 |
| UBS | John Lovallo | $154 | $119.2 | +13.8% | May 22, 2024 |
| UBS | John Lovallo | $140 | $120.21 | +3.5% | May 22, 2024 |
| Wells Fargo | Deepa Raghavan | $150 | $127.38 | +10.9% | May 15, 2024 |
| Oppenheimer | Tyler Batory | $157 | $126.53 | +16.1% | Mar 21, 2024 |
| Raymond James | Buck Home | $120 | $102.36 | -11.3% | Feb 20, 2024 |
| Wolfe Research | Truman Patterson | $118 | $102.16 | -12.8% | Jan 8, 2024 |
| Wedbush | Jay McCanless | $82 | $86.88 | -39.4% | Dec 5, 2023 |
| Raymond James | Buck Horne | $100 | $75.93 | -26.1% | Aug 22, 2023 |
| Credit Suisse | Dan Oppenheim | $73 | $67.38 | -46.0% | May 31, 2023 |
| RBC Capital | Analyst unavailable | $49 | $49.5 | -63.8% | Dec 8, 2022 |
| Barclays | Analyst unavailable | $50 | $49.5 | -63.0% | Dec 8, 2022 |
| J.P. Morgan | Analyst unavailable | $58 | $45.6 | -57.1% | Nov 22, 2022 |
| UBS | Analyst unavailable | $59 | $44.38 | -56.4% | Jun 16, 2022 |
| Credit Suisse | Daniel Oppenheim | $63 | $45.8 | -53.4% | Apr 8, 2022 |
| Wells Fargo | Deepa Raghavan | $82 | $71.6 | -39.4% | Dec 13, 2021 |
| Janney Montgomery | Tyler Batory | $91 | $72.23 | -32.7% | Dec 9, 2021 |
| Goldman Sachs | Susan Maklari | $60 | $72.23 | -55.6% | Dec 9, 2021 |
| Wedbush | Jay McCanless | $73 | $72.23 | -46.0% | Dec 9, 2021 |
Track every rating change on TOL the moment it posts. Free to start.
Start freeToll Brothers, Inc. (TOL) stands as a prominent luxury homebuilder operating across the United States. The company, along with its various divisions, specializes in the design, construction, marketing, sale, and financing of upscale detached and attached residences within master-planned communities. Its operations are structured into two main divisions: Traditional Home Building and City Living. The latter specifically focuses on developing, constructing, and selling condominiums. Beyond its core homebuilding activities, Toll Brothers diversifies its portfolio by developing and managing golf courses and country clubs, acquiring and divesting land, and constructing, operating, and leasing apartment complexes.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.6% | +3.3% | AutoZone pairs commercial momentum with an aggressive FY2027 expansion plan |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| LULU Lululemon Athletica Inc. | FY2026 Q2 · Calendar Q3 2026 | +63.1% | -17.4% | Lululemon lowers FY2026 outlook as North America weakens |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.